caffeic acid phenethyl ester has been researched along with octyl gallate in 1 studies
Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (octyl gallate) | Trials (octyl gallate) | Recent Studies (post-2010) (octyl gallate) |
---|---|---|---|---|---|
840 | 1 | 469 | 110 | 0 | 57 |
Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | octyl gallate (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 8.74 | |
Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | 4.04 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 2.56 | |
Squalene monooxygenase | Rattus norvegicus (Norway rat) | 0.83 | |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 9.28 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 5.48 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Feng, F; Guo, Q; He, S; Liu, W; Liu, Y; Sun, H; Zhao, L | 1 |
1 review(s) available for caffeic acid phenethyl ester and octyl gallate
Article | Year |
---|---|
Overview of AKR1C3: Inhibitor Achievements and Disease Insights.
Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Binding Sites; Cell Proliferation; Clinical Trials as Topic; Drug Development; Drug Resistance, Neoplasm; Humans; Models, Molecular; Molecular Structure; Neoplasms; Treatment Outcome | 2020 |